4D Molecular Therapeutics, Inc. (FDMT) Stock

Healthcare · Biotechnology · Member of Other US Stocks

4D Molecular Therapeutics, Inc. (FDMT) closed at USD 12.87 on 2026-10-15, a change of +12.8 % over the past year, with a market capitalization of USD 670.66M.

4D Molecular Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

4D Molecular Therapeutics, Inc. key figures

Previous close

USD 12.87 (2026-10-15)

1-year change

+12.8 %

Market cap

USD 670.66M

Enterprise value

USD 348.55M

P/E ratio (trailing)

-4.62

P/E ratio (forward)

-2.97

EPS (trailing)

-2.63

EPS (forward)

-4.09

PEG ratio

n/a

Price to book

1.64

Revenue growth

25,106.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

11.58

Employees

196

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About 4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company's lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. It is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in preclinical stage for treating geographic atrophy; and 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Otsuka Pharmaceutical Co., Ltd. The company was founded in 2013 and is headquartered in EmeryVille, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for 4D Molecular Therapeutics, Inc. and compare it with other stocks.